Coronary Artery Disease

References

Citations

1. Williams CL, et al. (2002). Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 106(1): 143–160.

2. McSweeney JC, et al. (2003). Women's early warning symptoms of acute myocardial infarction. Circulation, 108(21): 2619–2623.

3. American Heart Association (2006). Heart disease and stroke statistics—2006 update. Circulation, 113(6): e85–e151.

4. Grundy SM (2001). United States cholesterol guidelines 2001: Expanded scope of intensive low-density lipoprotein-lowering therapy. American Journal of Cardiology, 88(7B): 23J–27J.

5. U.S. Preventive Services Task Force, Agency for Healthcare and Research (2003). Screening for Diabetes Mellitus, Adult Type 2. Available online: http://www.ahrq.gov/clinic/uspstf/uspsdiab.htm.

6. Koenig W (2001). Inflammation and coronary artery disease: An overview. Cardiology in Review, 9(1): 31–35.

7. Snow V, et al. (2004). Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 141(7): 562–567. Also available online: http://www.annals.org/cgi/reprint/141/7/562.pdf.

8. Goldenberg I, et al. (2003). Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Archives of Internal Medicine, 163(19): 2301–2305.

9. Silagy C, et al. (2006). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

10. Jolliffe JA, et al. (2006). Exercise-based rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

11. Hayden M, et al. (2002). Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 136(2): 161–172.

12. Foster C, et al. (2004). Cardiovascular disorders: Primary prevention. Clinical Evidence (12): 159–192.

13. Smith SC Jr, et al. (2006). ACC/AHA/SCAI 2005 guidelines update for percutaneous coronary intervention: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation, 113(1): 156–175.

14. Gami A (2006). Secondary prevention of ischaemic cardiac events, search date July 2004. Online version of Clinical Evidence (15): 1–31.

15. Morice M (2002). A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New England Journal of Medicine, 346(23): 1773–1780.

Go to previous section	Go to top of page	Go to next section
Author:	Robin Parks, MS	Last Updated: January 8, 2008
Medical Review:	Caroline S. Rhoads, MD - Internal Medicine Robert A. Kloner, MD, PhD - Cardiology Ruth Schneider, MPH, RD - Diet and Nutrition
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.